PROQR THERAPEUTICS (Germany) Market Value

0PQ Stock  EUR 3.41  0.21  6.56%   
PROQR THERAPEUTICS's market value is the price at which a share of PROQR THERAPEUTICS trades on a public exchange. It measures the collective expectations of PROQR THERAPEUTICS EO 04 investors about its performance. PROQR THERAPEUTICS is trading at 3.41 as of the 29th of November 2024. This is a 6.56% up since the beginning of the trading day. The stock's lowest day price was 3.41.
With this module, you can estimate the performance of a buy and hold strategy of PROQR THERAPEUTICS EO 04 and determine expected loss or profit from investing in PROQR THERAPEUTICS over a given investment horizon. Check out PROQR THERAPEUTICS Correlation, PROQR THERAPEUTICS Volatility and PROQR THERAPEUTICS Alpha and Beta module to complement your research on PROQR THERAPEUTICS.
Symbol

Please note, there is a significant difference between PROQR THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if PROQR THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PROQR THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PROQR THERAPEUTICS 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PROQR THERAPEUTICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PROQR THERAPEUTICS.
0.00
06/08/2023
No Change 0.00  0.0 
In 1 year 5 months and 25 days
11/29/2024
0.00
If you would invest  0.00  in PROQR THERAPEUTICS on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding PROQR THERAPEUTICS EO 04 or generate 0.0% return on investment in PROQR THERAPEUTICS over 540 days. PROQR THERAPEUTICS is related to or competes with 24SEVENOFFICE GROUP, DFS Furniture, LGI Homes, Avanos Medical, American Homes, and CITY OFFICE. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics... More

PROQR THERAPEUTICS Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PROQR THERAPEUTICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PROQR THERAPEUTICS EO 04 upside and downside potential and time the market with a certain degree of confidence.

PROQR THERAPEUTICS Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for PROQR THERAPEUTICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PROQR THERAPEUTICS's standard deviation. In reality, there are many statistical measures that can use PROQR THERAPEUTICS historical prices to predict the future PROQR THERAPEUTICS's volatility.
Hype
Prediction
LowEstimatedHigh
0.173.4119.94
Details
Intrinsic
Valuation
LowRealHigh
0.132.5819.11
Details

PROQR THERAPEUTICS Backtested Returns

PROQR THERAPEUTICS is abnormally volatile given 3 months investment horizon. PROQR THERAPEUTICS maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11% return per unit of volatility over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.82% are justified by taking the suggested risk. Use PROQR THERAPEUTICS risk adjusted performance of 0.0944, and Semi Deviation of 3.01 to evaluate company specific risk that cannot be diversified away. PROQR THERAPEUTICS holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of -2.0, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PROQR THERAPEUTICS are expected to decrease by larger amounts. On the other hand, during market turmoil, PROQR THERAPEUTICS is expected to outperform it. Use PROQR THERAPEUTICS information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to analyze future returns on PROQR THERAPEUTICS.

Auto-correlation

    
  0.51  

Modest predictability

PROQR THERAPEUTICS EO 04 has modest predictability. Overlapping area represents the amount of predictability between PROQR THERAPEUTICS time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PROQR THERAPEUTICS price movement. The serial correlation of 0.51 indicates that about 51.0% of current PROQR THERAPEUTICS price fluctuation can be explain by its past prices.
Correlation Coefficient0.51
Spearman Rank Test0.25
Residual Average0.0
Price Variance0.4

PROQR THERAPEUTICS lagged returns against current returns

Autocorrelation, which is PROQR THERAPEUTICS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PROQR THERAPEUTICS's stock expected returns. We can calculate the autocorrelation of PROQR THERAPEUTICS returns to help us make a trade decision. For example, suppose you find that PROQR THERAPEUTICS has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

PROQR THERAPEUTICS regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PROQR THERAPEUTICS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PROQR THERAPEUTICS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PROQR THERAPEUTICS stock over time.
   Current vs Lagged Prices   
       Timeline  

PROQR THERAPEUTICS Lagged Returns

When evaluating PROQR THERAPEUTICS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PROQR THERAPEUTICS stock have on its future price. PROQR THERAPEUTICS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PROQR THERAPEUTICS autocorrelation shows the relationship between PROQR THERAPEUTICS stock current value and its past values and can show if there is a momentum factor associated with investing in PROQR THERAPEUTICS EO 04.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in PROQR Stock

PROQR THERAPEUTICS financial ratios help investors to determine whether PROQR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PROQR with respect to the benefits of owning PROQR THERAPEUTICS security.